Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission (vol 30, pg 2796, 2024)
Por:
Bengu N, Cromhout G, Adland E, Govender K, Herbert N, Lim N, Fillis R, Sprenger K, Vieira V, Kannie S, van Lobenstein J, Chinniah K, Kapongo C, Bhoola R, Krishna M, Mchunu N, Pascucci GR, Cotugno N, Palma P, Tagarro A, Rojo P, Roider J, Garcia-Guerrero MC, Ochsenbauer C, Groll A, Reddy K, Giaquinto C, Rossi P, Hong S, Dong K, Ansari MA, Puertas MC, Ndung'u T, Capparelli E, Lichterfeld M, Martinez-Picado J, Kappes JC, Archary M and Goulder P
Publicada:
1 may 2025
Ahead of Print:
1 feb 2025
Resumen:
Filiaciones:
Bengu N:
Queen Nandi Regional Hospital, Empangeni, South Africa
HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
Cromhout G:
HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
Department of Paediatrics, University of KwaZulu-Natal, Durban, South Africa
Adland E:
Department of Paediatrics, University of Oxford, Oxford, UK
Govender K:
Africa Health Research Institute, Durban, South Africa
Herbert N:
Department of Paediatrics, University of Oxford, Oxford, UK
Lim N:
Department of Paediatrics, University of Oxford, Oxford, UK
Fillis R:
Harry Gwala Regional Hospital, Pietermaritzburg, South Africa
Sprenger K:
HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
Vieira V:
Department of Paediatrics, University of Oxford, Oxford, UK
Kannie S:
General Justice Gizenga Mpanza Regional Hospital, Stanger, South Africa
van Lobenstein J:
General Justice Gizenga Mpanza Regional Hospital, Stanger, South Africa
Chinniah K:
Mahatma Gandhi Memorial Hospital, Durban, South Africa
Kapongo C:
Queen Nandi Regional Hospital, Empangeni, South Africa
Bhoola R:
Harry Gwala Regional Hospital, Pietermaritzburg, South Africa
Krishna M:
Harry Gwala Regional Hospital, Pietermaritzburg, South Africa
Mchunu N:
HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
Pascucci GR:
Clinical Immunology and Vaccinology Unit, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy
Probiomics S.r.l., Rome, Italy
Cotugno N:
Clinical Immunology and Vaccinology Unit, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy
University of Rome Tor Vergata, Rome, Italy
Palma P:
Clinical Immunology and Vaccinology Unit, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy
University of Rome Tor Vergata, Rome, Italy
Tagarro A:
Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain
Department of Pediatrics, Infanta Sofia University Hospital and Henares University Hospital Foundation for Biomedical Research and Innovation, Madrid, Spain
Universidad Europea de Madrid, Madrid, Spain
Rojo P:
Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain
Roider J:
LMU University Hospital, Munich, Germany
Garcia-Guerrero MC:
IrsiCaixa AIDS Research Institute, Barcelona, Spain
Ochsenbauer C:
University of Alabama at Birmingham, Birmingham, AL, USA
Groll A:
TU Dortmund University, Dortmund, Germany
Reddy K:
Africa Health Research Institute, Durban, South Africa
Giaquinto C:
University of Padova, Padua, Italy
Rossi P:
Clinical Immunology and Vaccinology Unit, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy
University of Rome Tor Vergata, Rome, Italy
Hong S:
Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA
Dong K:
Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA
Ansari MA:
Nuffield Department of Medicine, University of Oxford, Oxford, UK
:
IrsiCaixa AIDS Research Institute, Barcelona, Spain
Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
Ndung'u T:
HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
Africa Health Research Institute, Durban, South Africa
Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA
Division of Infection and Immunity, University College London, London, UK
Capparelli E:
University of California San Diego, San Diego, CA, USA
Lichterfeld M:
Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA
:
IrsiCaixa AIDS Research Institute, Barcelona, Spain
Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
Infectious Diseases and Immunity Department, University of Vic-Central University of Catalonia, Vic, Spain
Kappes JC:
University of Alabama at Birmingham, Birmingham, AL, USA
Birmingham Veterans Affairs Medical Center, Research Service, Birmingham, AL, USA
Archary M:
Department of Paediatrics, University of KwaZulu-Natal, Durban, South Africa
Goulder P:
HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
Department of Paediatrics, University of Oxford, Oxford, UK
Africa Health Research Institute, Durban, South Africa
Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA
Green Submitted, hybrid
|